Literature DB >> 34585338

Ulinastatin Attenuates LPS-Induced Inflammation and Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis in Renal Tubular Epithelial Cells via Regulation of the TLR4/NF-κB and Nrf2/HO-1 Pathways.

Feixiang Chen1, Jiadong Zhu1, Wei Wang2.   

Abstract

Acute kidney injury (AKI) is one of the most common diseases in patients treated in intensive care units. This study was intended to explore the underlying mechanism by which ulinastatin (UTI) influenced the inflammation and apoptosis of renal tubular epithelial cells, HK-2.The effects of UTI on the cell viability of HK-2 cells were first measured by MTT and lactate dehydrogenase (LDH) detection kit. The apoptosis and inflammation of HK-2 cells were then determined by TUNEL, western blot, ELISA, and RT-qPCR. Then, the proteins in the Toll-like receptor 4 (TLR4)/nuclear factor κB (NF-κB) and nuclear factor erythroid 2-related factor 2 (Nrf2)/Heme oxygenase 1 (HO-1) signaling pathways were measured by western blot for confirming the relationship between UTI and these pathways. Finally, Nrf-2 inhibitor ML385 and TLR4 activator CCL-34 were respectively used on LPS-induced HK-2 cells exposed to UTI for the conduction of gain-of-function and loss-of-function assays.UTI treatment boosted the cell viability of HK-2 cells damaged by LPS. Furthermore, UTI exposure cut down the apoptosis rate and inhibited the expression inflammatory factors of HK-2 cells induced by LPS. UTI treatment decreased the expression of proteins in the TLR4/NF-κB pathway, increased the HO-1 expression, and prompted the translocation of Nrf2 from the cytoplasm to the nucleus. The alleviated effects of UTI on inflammation and apoptosis LPS-induced HK-2 cells were abolished by ML385 and TLR4, respectively.UTI attenuates LPS-induced inflammation and inhibits endoplasmic reticulum stress-induced apoptosis in renal tubular epithelial cells by regulating TLR4/NF-κB and Nrf2/HO-1 pathways.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acute kidney injury; Inflammation; Renal tubular epithelial cells; TLR4/NF-κB and Nrf2/HO-1 pathways; Ulinastatin

Mesh:

Substances:

Year:  2021        PMID: 34585338     DOI: 10.1007/s10753-021-01505-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  4 in total

1.  Ulinastatin improves myocardial ischemia-reperfusion injury in rats through endoplasmic reticulum stress-induced apoptosis pathway.

Authors:  M-H Lun; X-Y Jin; M-Y Wang; Z Cai; W Du; Z-Q Huang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2020-05       Impact factor: 3.507

2.  Pachymic acid ameliorates sepsis-induced acute kidney injury by suppressing inflammation and activating the Nrf2/HO-1 pathway in rats.

Authors:  Z-Y Cai; Z-X Sheng; H Yao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-04       Impact factor: 3.507

3.  Effects of ulinastatin on renal ischemia-reperfusion injury in rats.

Authors:  Cong-Cong Chen; Zi-Ming Liu; Hui-Hua Wang; Wei He; Yi Wang; Wei-Dong Wu
Journal:  Acta Pharmacol Sin       Date:  2004-10       Impact factor: 6.150

4.  Isoliquiritigenin Ameliorates Acute Pancreatitis in Mice via Inhibition of Oxidative Stress and Modulation of the Nrf2/HO-1 Pathway.

Authors:  Xinnong Liu; Qingtian Zhu; Min Zhang; Tao Yin; Rong Xu; Weiming Xiao; Jian Wu; Bin Deng; Xuefeng Gao; Weijuan Gong; Guotao Lu; Yanbing Ding
Journal:  Oxid Med Cell Longev       Date:  2018-04-26       Impact factor: 6.543

  4 in total
  2 in total

1.  Ulinastatin Alleviates Rhabdomyolysis-Induced Acute Kidney Injury by Suppressing Inflammation and Apoptosis via Inhibiting TLR4/NF-κB Signaling Pathway.

Authors:  Jinxiang Wang; Guowu Xu; Heng Jin; Yanfen Chai; Xinyue Yang; Ziquan Liu; Shike Hou; Haojun Fan
Journal:  Inflammation       Date:  2022-06-06       Impact factor: 4.657

2.  Ulinastatin alleviates pulmonary edema by reducing pulmonary permeability and stimulating alveolar fluid clearance in a rat model of acute lung injury.

Authors:  Yuan-Xu Jiang; Ze-Wei Huang
Journal:  Iran J Basic Med Sci       Date:  2022-08       Impact factor: 2.532

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.